3 years ago

CardiaTec Raises £1.4 Million to Develop AI-Powered Heart Disease Treatment

  • CardiaTec, a Cambridge-based health tech startup, has secured £1.4 million in pre-seed funding to advance its AI-driven cardiovascular disease treatment platform

  • The investment round was led by Laidlaw Scholars Ventures (LSV) and APEX Ventures, with participation from Crista Galli Ventures, o2h ventures, and Cambridge Enterprise

  • CardiaTec's platform analyzes large-scale cardiovascular data to gain insights into heart disease development, aiming to improve patient outcomes.

      • ProblemHealthcare

      "Cardiovascular disease research has been under-invested in resulting in a lack of innovation in treatments that meet patients' needs."

      Solution

      "Developing an AI-driven target discovery platform that analyses large-scale cardiovascular data across different fields of biology to drive new and meaningful insights for improved treatments."

      Covered on